Evaluation of the performances of InnowaveDx MTB-RIF assay in the diagnosis of pulmonary tuberculosis using bronchoalveolar lavage fluid - 29/05/23
, Long Cai ⁎ Abstract |
Objective |
To evaluate the tuberculosis diagnostic performance of the InnowaveDx MTB-RIF assay (InnowaveDx test) in bronchoalveolar lavage fluid (BALF).
Methods |
A total of 213 BALF samples from suspected PTB patients were analyzed. AFB smear, culture, Xpert, Innowavedx test, CapitalBio test and simultaneous amplification and testing (SAT) were performed.
Results |
Of the 213 patients included in the study, 163 were diagnosed with PTB, and 50 were TB negative. Using the final clinical diagnosis as the reference, the sensitivity of InnowaveDx assay was 70.6%, which was significantly higher than the values achieved using the other methods (P < 0.05), and the specificity was 88.0%, which was comparable with other methods (P > 0.05). Among the 83 PTB cases with negative culture results, the detection rate of InnowaveDx assay was significantly higher than those of AFB smear, Xpert, CapitalBio test and SAT (P < 0.05). Kappa analysis was used to compare the agreement of InnowaveDx and Xpert in detecting RIF sensitivity, and the result showed the Kappa value was 0.78.
Conclusions |
The InnowaveDx test is a sensitive, rapid and cost-effective tool for PTB diagnosis. In addition, the sensitivity of InnowaveDx to RIF in samples with low TB load should be interpreted with caution in light of other clinical data.
Le texte complet de cet article est disponible en PDF.Highlights |
• | A variety of methods diagnosing pulmonary tuberculosis were evaluated. |
• | BALF was used to evaluate the diagnostic performance of InnowaveDx test, which may be helpful for patients with smear-negative or sparse sputum. |
• | The InnowaveDx test is a sensitive, rapid and economical diagnostic tool for PTB. |
Keywords : Pulmonary tuberculosis, Diagnosis, Bronchoalveolar lavage fluid, Xpert MTB/RIF, InnowaveDx MTB-RIF
Plan
Vol 140
Article 102349- mai 2023 Retour au numéro
Article précédent
- Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis
- Jiahui Zhu, Jia Liu, Ziwei Bao, Hong Cao, Sainan Wang, Xuliang Li, Zhu Ning, Sven Hoffner, Yi Hu, Lina Davies Forsman
- In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis
- Chi Zhang, Qi Ouyang, Xianyuan Zhou, Yingfeng Huang, Yu Zeng, Li Deng, Dachuan Lin, Weidong Zheng
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?